Anti-MAOA Antibody

This polyclonal reagent from Antibodies.com targets monoamine oxidase A (MAOA), the flavin-containing enzyme anchored to the outer mitochondrial membrane that catalyses the oxidative deamination of biogenic amines including serotonin, norepinephrine, dopamine, and tyramine. Raised in rabbits and supplied at 1 mg/ml in PBS with 0.1% sodium azide and 50% glycerol, the antibody is unconjugated and validated for western blot and immunohistochemistry on human, mouse, and rat specimens. Each vial contains 100 µl of working stock ready for titration across standard immunodetection protocols, and the 50% glycerol carrier keeps the protein stable at -20 °C with minimal freeze-thaw risk. Investigators studying neurotransmitter catabolism, mitochondrial enzyme expression, or the pharmacology of MAO inhibitors such as clorgyline and moclobemide rely on this reagent to probe tissue distribution in brain, liver, and peripheral samples, while cancer researchers use it to characterise MAOA overexpression reported in glioblastoma and prostate cancer models. The polyclonal format broadens epitope coverage, which helps recover weak bands on PVDF membranes and improves cytoplasmic staining in paraffin-embedded IHC sections.